Skip to content

Lantheus Holdings LNTH Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
Cardinal Health logo
Cardinal HealthCAH

Other financials

Income statement

See full
Revenue$377.3M+1.2%
Gross profit$230.9M-2.9%
Operating income$81.3M-20.3%
Net income$118.4M+62.3%
EPS (diluted)$1.80+76.5%

Balance sheet

See full
Cash & equivalents$500.3M-46.8%
Total debt$627.9M+1.8%
Total equity$1.2B+4.1%
Total assets$2.3B+14.2%

Cash flow

See full
Operating cash flow$125.1M+16.3%
CapEx$3.2M-63.0%
Free cash flow$121.9M+23.3%

Valuation

See full
Market cap$6.76B-26.3%
Enterprise value$6.89B-20.5%
P/E24.2×-10.2×
P/S4.4×-1.6×

Profitability

See full
Gross margin60.5%-3.6pp
Operating margin18.8%-10.7pp
Net margin18%+0.7pp
FCF margin24.4%-6.4pp

Returns & leverage

See full
Return on equity23.5%-1.7pp
Debt / equity0.5×0.0×
Current ratio2.8×-2.9×

Where this comes from

Reported directly by Lantheus Holdings in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: Lantheus Holdings’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lantheus Holdings's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lantheus Holdings's treasury stock, shares (in shares)?
Lantheus Holdings (LNTH) reported treasury stock, shares (in shares) of $7.24M in Q1 2026.
How has Lantheus Holdings's treasury stock, shares (in shares) changed year-over-year?
Lantheus Holdings's treasury stock, shares (in shares) increased by 194.9% year-over-year, from $2.46M to $7.24M.
What is the long-term trend for Lantheus Holdings's treasury stock, shares (in shares)?
Over 3 years (2022 to 2025), Lantheus Holdings's treasury stock, shares (in shares) has grown at a 75.5% compound annual growth rate (CAGR), from $1.34M to $7.24M.